China’s NMPA approves Henlius’ oesophageal cancer therapy
The treatment is indicated for usage in PD-L1 positive unresectable locally advanced/recurrent or metastatic oesophageal squamous cell carcinoma patients. Credit: Kateryna Kon / Shutterstock.com. China’s